glovaxbiotech.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Glovax Biotech |
| Description | Featured Who we are Glovax Biotech Corporation is a fully integrated vaccine company seeking to drastically improve immunization coverage in the country, primarily |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 148.66.138.136 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
glovaxbiotech.com Valuation
|
US$1,124
Last updated: 2023-05-09 20:39:52
glovaxbiotech.com has Semrush global rank of 0. glovaxbiotech.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. glovaxbiotech.com receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 148.66.138.136. According to SiteAdvisor, glovaxbiotech.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| glovaxbiotech.com. | A | 7199 | IP: 148.66.138.136 |
| glovaxbiotech.com. | NS | 3600 | NS Record: ns30.domaincontrol.com. |
| glovaxbiotech.com. | NS | 3600 | NS Record: ns29.domaincontrol.com. |
| glovaxbiotech.com. | MX | 3600 | MX Record: 0 smtp.secureserver.net. |
| glovaxbiotech.com. | MX | 3600 | MX Record: 10 mailstore1.secureserver.net. |
| glovaxbiotech.com. | TXT | 3600 | TXT Record: D9201222 |
HtmlToTextCheckTime:2023-05-09 20:39:52
| Who we are Glovax Biotech Corporation is a fully integrated vaccine company seeking to drastically improve immunization coverage in the country, primarily for middle to low income Filipinos, by finding innovative ways to increase the availability, affordability, and awareness of vaccines. What we are doing At present, we are devoting much of our attention and resources to help alleviate the spread of Covid-19 in the Philippines. We have recently partnered with Korean firm EuBiologics to locally produce and distribute EuCorVac-19 which was developed in the United States by POP Biotechnologies. EuCorVac-19 is a genetic recombinant with a vaccine adjuvant and has demonstrated excellent immunogenicity and safety. Unlike other Covid-19 vaccines, it does not require cryogenic temperature, making storage and distribution more convenient as well as helping keep costs down. We are in the early stages of constructing a state of the art vaccine and biotech research and development facility, that |
HTTP Headers
HTTP/1.1 200 OK Date: Mon, 01 Nov 2021 12:17:12 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Sat, 17 Jul 2021 06:50:17 GMT ETag: "bd0007d-524e-5c74c1df0a755" Accept-Ranges: bytes Cache-Control: max-age=0 Expires: Mon, 01 Nov 2021 12:17:12 GMT Vary: Accept-Encoding,User-Agent Content-Type: text/html |
glovaxbiotech.com Whois Information
Domain Name: GLOVAXBIOTECH.COM Registry Domain ID: 1572219744_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-06-18T14:39:10Z Creation Date: 2009-10-14T07:28:30Z Registry Expiry Date: 2021-10-14T07:28:30Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: ok https://icann.org/epp#ok Name Server: NS29.DOMAINCONTROL.COM Name Server: NS30.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T21:20:56Z <<< |